Strategies to Prevent and Manage Thrombotic Complications of Acute Lymphoblastic Leukemia in Children and Young People Vary Between Centers in the United Kingdom. Issue 3 (April 2016)
- Record Type:
- Journal Article
- Title:
- Strategies to Prevent and Manage Thrombotic Complications of Acute Lymphoblastic Leukemia in Children and Young People Vary Between Centers in the United Kingdom. Issue 3 (April 2016)
- Main Title:
- Strategies to Prevent and Manage Thrombotic Complications of Acute Lymphoblastic Leukemia in Children and Young People Vary Between Centers in the United Kingdom
- Authors:
- Biss, Tina T.
Payne, Jeanette H.
Hough, Rachael E.
Grainger, John D.
Macartney, Christine
Sibson, Keith R.
Chalmers, Elizabeth A. - Abstract:
- Abstract : There is a lack of evidence-based guidance for the prevention and management of thrombosis in children and young people treated for acute lymphoblastic leukemia. To determine current UK practice, a survey was sent to 28 centers participating in the Medical Research Council UKALL 2011 trial. Marked variation in practice was noted. In total, 43% of centers defer central venous access device insertion until end of induction for treatment of low-risk disease. Central venous access devices are removed at the end of intensive blocks in 38% and end of treatment in 42%. Duration of anticoagulation for line-associated thrombosis is 6 weeks in 43% and 3 months in 33% and for cerebral sinovenous thrombosis is 3 months in 71% and 6 months in 24%. Platelet transfusion to maintain platelet count >50×10 9 /L, in preference to interrupting therapeutic anticoagulation, is used by 50% for line-associated thrombosis and 73% for cerebral sinovenous thrombosis. Conformity of practice was seen in some areas. In total, 70% treat thrombosis with twice-daily low–molecular weight heparin and 86% monitor antifactor Xa activity levels. In total, 91% reexpose individuals to asparaginase following a thrombotic event. Given this variation in practice, in the absence of high-quality evidence, consensus guidelines may be helpful.
- Is Part Of:
- Journal of pediatric hematology/oncology. Volume 38:Issue 3(2016)
- Journal:
- Journal of pediatric hematology/oncology
- Issue:
- Volume 38:Issue 3(2016)
- Issue Display:
- Volume 38, Issue 3 (2016)
- Year:
- 2016
- Volume:
- 38
- Issue:
- 3
- Issue Sort Value:
- 2016-0038-0003-0000
- Page Start:
- Page End:
- Publication Date:
- 2016-04
- Subjects:
- acute lymphoblastic leukemia -- anticoagulation -- central venous access device -- thrombophilia -- thrombosis
Pediatric hematology -- Periodicals
Tumors in children -- Periodicals
618.9215 - Journal URLs:
- http://journals.lww.com/jpho-online/pages/default.aspx ↗
http://gateway.tx.ovid.com/ovidweb.cgi?T=JS&MODE=ovid&NEWS=n&PAGE=toc&D=ovft&AN=00043426-000000000-00000 ↗
http://www.jpho-online.com/ ↗
http://journals.lww.com/jpho-online/pages/default.aspx ↗
http://journals.lww.com ↗ - DOI:
- 10.1097/MPH.0000000000000538 ↗
- Languages:
- English
- ISSNs:
- 1077-4114
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 5030.183000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 5133.xml